SGO: Reduced Opioid Use With Liposomal Bupivacaine in Surgery

Medpage Today

Action Points

• Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
• Note that this observational study using historical controls suggested that liposomal bupivacaine may decrease subsequent opioid use among women undergoing surgery for gynecologic malignancy.